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Abstract
Background: Little is known on outcomes after transition to adult care among adolescents with perinatal HIV
infection. Though there is data from other chronic pediatric diseases suggesting increased morbidity and mortality
following transfer to adult care, this has not well been studied among the first wave of survivors of perinatal HIV
infection. The primary objective of this study was to determine outcomes after transition to adult care among
a cohort of HIV-infected adolescents in Québec, Canada. Secondary objectives were to document participant
experiences with the transition process, identify barriers to successful transition, and potential changes to improve
the transition process.
Methods: Clinic records were reviewed to identify all perinatally-infected youth who transitioned from the Centre
Maternel et Infantile sur le Sida pediatric HIV clinic (Montreal) at age 18 to an adult care provider between 1999
and 2012. Transitioned patients were contacted using last available patient or parental listed phone number on
hospital record, internet based telephone directory, or social media. A standardized questionnaire was administered
by telephone or in-person interview, and copies of current medical records obtained from treating physicians.
Results: Forty-five patients were transferred between 1999 and 2012, among whom 25 consented to the study,
eight were lost to follow-up, eight refused participation, and four were deceased. Overall 76 % of patients remained
engaged in care, defined by at least one physician visit within 6 months of the interview. Over 50 % reported
difficulty with adherence to their current drug regimens. At one-year post-transfer, there was a decrease in the
proportion of patients with CD4 count >500 cells/mm3 from 64 to 29 %, and a statistically significant decrease
in absolute CD4 count (mean 370 vs 524 cells/mm3, p = 0.04.). The majority (92 %) of participants felt that 18 was
too young an age to transfer to adult care, and provided suggestions for improving the transition process.
Conclusions: This group of perinatally-infected youth remained engaged in care after transition, however
difficulties with adherence and assuming responsibility for their own care were identified as issues in their
post-transition care. The high rate of mortality among them and the changes to their health status post-transition
suggest that further work is necessary to document the health outcomes of this group in larger, more diverse
cohort settings.
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Background
The success of combination antiretroviral therapy
(cART) has changed the course of pediatric HIV from a
once fatal disease to a chronic one [1]. Worldwide, in-
creasing numbers of perinatally-infected children have
reached the age at which they will need to transition
from pediatric to adult care. Transition, formally defined
as the “purposeful, planned movement of adolescents
with chronic medical conditions from child-centered to
adult-oriented health care” [2], has historically been
challenging [3, 4]. Though there is a wealth of informa-
tion from other chronic pediatric diseases that illustrates
that the transition process is often associated with in-
creased morbidity, mortality, poorer social and educa-
tional outcomes, and high rates of loss to follow-up and
non-retention in care [5–7], adolescents with HIV have
unique characteristics when compared to other pediatric
populations, which make it difficult to extrapolate data
from transition studies of other chronic diseases [8].
While the normal transition process is marked by a
sense of loss and grief that occurs when going from one
life stage to another, this change may be experienced
more intensely for young adults living with HIV, as
many have already suffered the loss of important care-
givers in their lives, including the death of one or more
parent [9]. The break of ties with pediatric staff with
whom they may have developed longstanding relation-
ships may represent additional loss [10, 11]. Moreover,
as a chronic illness, HIV is unique because of HIV-
related stigma, the relationship to poverty, and the fact
that multiple members of the same family may be living
with or have died from HIV infection [12, 13]. Emerging
data on outcomes after transition among perinatally-
infected youth is concerning; a recent study from the US
HIV Research Network found that 19.8 % of transitioned
21 year-olds were lost-to-follow-up after their 22nd-
birthday [14], and had lower prevalence of virological
suppression compared with horizontally-infected young
adults [15]. A similar study among 20–24 year olds in
the UK found a significantly higher mortality rate com-
pared to HIV uninfected youth [16].
The Centre Maternel et Infantile sur le Sida (CMIS)
cohort was established in 1988 to follow all HIV-
infected children in care at Centre Hospitalier Universi-
taire (CHU) Sainte-Justine, a tertiary care hospital, in
Montréal, Canada. Under a system of universal health
care access, children received cART as soon as it became
available in 1997 and were followed until age 18, at
which point they were transferred to adult care. We
previously described the clinical and immunological
status of these adolescents at the time of transfer [17], and
found alarmingly that over two thirds were failing treat-
ment, manifested by detectable viremia, CD4 counts <200
cells/mm3, and/or triple class resistance. Given concerns
about their health status prior to transition, and the pau-
city of data on post-transition outcomes, the primary ob-
jective of this study was to determine outcomes after
transition to adult care among this cohort of HIV-infected
adolescents in Québec, Canada, a province with one of
the youngest ages of transition in the developed world.
Secondary objectives were to document participant expe-
riences with the transition process, identify barriers to




Clinic records were reviewed to identify all youth who
were transferred from the CMIS to an adult care pro-
vider between 1999 and 2012. Inclusion criteria for the
study included 1) Perinatal HIV infection 2) Engaged in
care prior to transfer (attendance at least 3 appoint-
ments per year in the 2 years prior to transfer) 3)
Capacity to communicate (verbally or written), and 4)
Elapsed time of at least 1 year since transfer. After the
study was approved by the Institutional Review Board of
CHU Sainte-Justine Research Center, patients were con-
tacted by the CMIS research nurse for consent to enter
into the study using last available patient or parental
listed phone number on hospital record, internet
based telephone directory (Canada 411), or social
media (Facebook).
Procedure
For those who consented to the study, a semi-structured
standardized questionnaire was administered by tele-
phone or in-person interview by the CMIS research
nurse, and permission obtained to contact their current
treating physicians for their medical records. Participants
interviewed by telephone were offered a gift card of 50$
to compensate them for their time, and those inter-
viewed in person were supplemented with $20 to com-
pensate for travel. In addition to the structured
questionnaire, participants were asked the following
three questions to describe their experience with the
transfer of care.
1) Do you feel that you were ready to transfer to adult
care at age 18?
2) Are you satisfied with your new adult care provider?
Why or why not?
3) Do you have suggestions for improving the
transition process?
Responses were transcribed verbatim and entered into
a central database after which they were translated into
English. Responses were grouped by theme according to
the questions asked, and quoted in the text to illustrate
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the diversity of answers (those which were repeated were
not quoted). Descriptive statistics were used to describe
the study population, and paired-t-test was used to com-
pare pre-and post-transition CD4 count. All data was
analyzed using STATA vs.13.0.
The transition process
By age 18, the care of HIV-infected children was offi-
cially transferred to an adult care provider. Patients were
given a choice of an adult care provider closest to them,
and were accompanied to their first visit by the pediatric
clinic social worker. At the time of the study there were
no other interventions in place to facilitate transfer of
care. A complete medical and psychosocial summary of
the patient was sent to the new adult treating physician.
After transfer, no further medical care was provided at
CMIS unless pregnancy occurred, at which point the pa-
tients were re-engaged by the obstetrics team at CHU
Sainte-Justine and their newborn infants followed at
CMIS for prevention of mother-to-child transmission.
Results
Fifty-four patients were transferred from the pediatric
clinic to an adult care provider between 1999 and 2012,
among whom 45 were eligible for study. Reasons for ex-
clusion included horizontal transmission (1), disengaged
in care prior to transfer (2), unable to communicate
(verbally or written) (3), and less than 1 year elapsed
since transfer (3). Among 45 eligible patients, 25 suc-
cessfully completed the study; 8 refused participation,
four were deceased at time of study, and eight could not
be reached. Among the eight who were not successfully
contacted, four were confirmed alive by family members
or their current physicians. All of the patients confirmed
deceased were transferred between 1999 and 2002.
Characteristics of the participants are described in
Table 1. Mean time that had elapsed between transfer
and interview was 3.6 years (range 1.1–6.8 years), and
mean age at time of interview was 22 years (range 19–
25 years). Sixty percent of the interviews were conducted
in person, 40 % by telephone. At the time of transfer,
92 % were still living with at least a parent and other
family member. Most (88 %) of the youth were accom-
panied to their first adult appointment by the pediatric
clinic social worker or a family member. At the time of
interview, the same percentage reported that they were
now going to their appointments by themselves.
Seventy-six percent remained engaged in care, defined
by at least one physician visit within 6 months of the
interview (as per standard Québec adult HIV treatment
follow-up guidelines) [18]. Fifty-two percent had ob-
tained a high school degree or higher, 64 % were still in
a school setting, and 33 % had completed their training
to date. Among those still in school, 50 % were also
working part-time. Twenty-five percent of the youth
were living on social assistance (Canadian welfare
program).
Medical outcomes
Prior to transfer, 64 % of patients had an absolute CD4
count greater than 500 cells/mm3, 16 % between 200
and 500 cells/mm3, and 20 % were immunosuppressed
with a CD4 count <200 cells/mm3. This changed at
1 year post-transfer, with a decrease in the proportion of
patients with CD4 counts >500 cells/mm3 to only 29 %,
and a corresponding increase in the proportion with
CD4 counts between 200 and 500 cells/mm3 and <200
cells/mm3 (41 % and 29 %, respectively). This repre-
sented a statistically significant decrease in absolute CD4
count (mean 370 vs. 524 cells/mm3, p = 0.04). With re-
spect to VL, prior to transfer, 60 % of patients had an
undetectable viral load VL (<40 copies/ml), while among
those who were detectable, all had VL>1000 copies/ml.
Among 16 patients for whom VL measures were avail-
able at 1 year, of the ten who had had undetectable VL
prior to transfer, nine remained undetectable, and one
increased VL (<40 to 1759 copies/ml). All six patients
with detectable VL prior to transfer remained detectable






Canadian Born 17 (68)
Foreign Born 8 (32)




No High School 7 (28)
High School 9 (36)
Professional degree 5 (20)
Pre college 4 (16)
University 0
Extended family without parents 7 (28)
Alone or with a partner 2 (8)
Living with at time of transfer
At least one parent 16 (64)
Last physician follow-up
Within past 6 months 19 (76)
Within past 12 months 3 (12)
Not for over 1 year 3 (12)
Kakkar et al. BMC Pediatrics  (2016) 16:109 Page 3 of 7
at 1 year post-transfer. At the time of the interview, only
seven youth remained on the same regimen they had
been on at the time of transfer, 11 had changed regimen,
two had stopped all ARV therapy, three who had not
been on treatment initiated therapy, and two still were
not on treatment. When asked how often they had
missed drug doses in the previous month, only 40 % of
patients reported excellent adherence to their current
drug regimens (no missed doses), 28 % reported occa-
sional missed doses, 16 % reported frequently missed
doses, and 12 % had stopped all ARV therapy.
Pregnancy, sexual health, and disclosure (Table 2)
Seventy-two percent of youth were self-described as
single, not in any significant relationship (defined as dat-
ing, married or living with their partner). Overall, 25 %
had become parents themselves (three women, two
men). Eighty percent of the youth stated that they had
regular sexual partners, to whom only 65 % routinely
disclosed their HIV status. Among those with occasional
sexual partners (n = 12), the majority (83 %) did not dis-
closure their HIV status to them. While only 60 % an-
swered that they always used condoms with their regular
sexual partners, 83 % stated they always used condoms
with their occasional sexual partners.
Reflections on the transition process
When asked whether they had felt ready to transition to
adult care at age 18, the majority of participants (92 %)
stated that they weren’t ready to transition at the age of
18, and would have preferred the option of staying lon-
ger under pediatric care. Specific comments on the age
of transition are listed below:
“I wasn’t ready, I would have preferred staying until at
least I knew how to make my own appointments and
go by myself. Here everyone helped, afterwards I was
on my own”. (19 year-old)
“18 was way too early. I wasn’t ready and I had a lot
of trouble, I had to go a whole month without my
medications because there was no one to help get
them, and my viral load went up”. (23-year-old)
“It was too much of a change too fast. 18 is too young
to leave kids all by themselves. Suddenly we were given
all new responsibilities, I had to my make my own
appointments and it was hard. I was used to the old
system where we had lots of help”. (19 year-old)
Suggestions on improving the transition process
Participants were then asked for suggestions on how to
improve the transition process. Themes that emerged in-
cluded allowing youth to maintain ties to non-medical
members of pediatric team and other youth in clinic, al-
ternating appointments between the adult and pediatrics
doctors until solid ties to the adult doctor had been
established, and being provided with more information
on what was going to happen in the adult clinics. Spe-
cific comments are below:
“ I would have liked to have visited the adult doctor a
few times, while still having medical appointments at
CMIS, until I was sure I felt comfortable with him and
I knew how to make my appointments and where to
go”. (24 year-old)
“ I would have preferred to have something in-between,
maybe an 18–25 year old clinic”. (19 year-old)
“I would have preferred to try different adult doctors
until I found one that was right for me”. (24 year-old)
“I was ok with the transfer of my medical
appointments to someone else, but I really would have
Table 2 Sexual Practices, Disclosure and Pregnancy among
Transitioned Youth
Response to questionnaire N (%)
I have regular sexual partners
Yes 20 (80)
No 5 (20)
I routinely disclose my HIV status to my regular sexual partners
Yes 13 (65)
No 7 (35)
I always use condoms with my regular sexual partners
Yes 12 (60)
No 8 (40)
I have occasional sexual partners
Yes 12 (48)
No 12 (52)
I disclose to my occasional sexual partners
Never 10 (83)
Occasionally 2 (17)
I always use condoms with my occasional sexual partners
Yes 10 (83)
No 2 (17)




Has become a parent (all respondents)
Yes 5 (25)
No 20 (75)
Ever pregnant (among females n = 15)
Yes 6 (40)
Termination 3 (50)
Live birth 3 (50)
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preferred to be able to keep my social worker until I
could find someone else to help”. (24 year-old)
“We should have been given more responsibility when
we were younger – around 16 – to do the things we
need to do on the adult side like making our own
appointments”. (20 year-old)
Reflections on their experience with adult care providers
Participants were then asked to describe their experience
with their new adult care providers and any difficulties
they were having. Their comments reflect a sense of dis-
satisfaction with the rapidity of appointments, the feeling
of being rushed and unable to connect to adult care
providers.
“The appointments go too fast on the adult side and
they give you little information. I would have liked
more information before I left, about how the
appointments would be, what kind of treatments there
would be”. (22 year-old)
“It (the appointment) goes too quickly on the adult
side – you’re done in 20 minutes, blood taken, the
doctors asks you how you are doing and gives you your
prescription. There isn’t any time to talk. They don’t
explain things”. (20 year-old)
“I feel the adult doctor doesn’t really care if I show up
or not” (21 year-old)
“The problem is that the visit only lasts for 5 min and
you only get to see the doctor. No one else seems to
care”. (23 year-old)
Discussion
This study is the first to report on post-transition out-
comes among perinatally-infected youth in Montréal,
Canada, in a province with one of the youngest ages of
transition in the developed world. Though only 25 pa-
tients participated (just over 50 % of those eligible), the
results highlight some common issues and some major
concerns in their post-transition care.
First, with respect to their overall medical status, it is
concerning that nearly a quarter of transitioned patients
were no longer engaged in care. This was reflected in
the change in their health status post-transfer, with a
notable decrease in their CD4 counts. In addition to lack
of engagement in care, we suspect that the changes
seen to CD4 count may also reflect difficulties with
adherence and drug procurement that have occurred
post-transition, which has previously been described
among transitioned youth in the United States [19].
While all young adults are covered by the provincial
health care plan in the province of Québec, participa-
tion in the system requires ongoing registration, which
many found difficult to do on their own. Moreover,
the same medications which were free of charge while
they were “children” (under age 18) now require a
monthly co-payment. Adult clinics receiving these
young adults have expectations that they are able to
assume responsibility for their own appointments, drug
coverage and costs, tasks that many adolescents are
not equipped for at the time of transfer. We were fur-
ther surprised at the low rate of excellent adherence
(by self-report) among the transitioned teens. The use
of self-report to measure adherence is generally biased
upwards due to both recall bias and the desire of re-
spondents to please interviewers [20]. In this respect,
a self reported excellent adherence rate of 40 % is
concerning. Moreover, the participants in the study
likely represent those most engaged in care and thus
likely to be adherent, perhaps overestimating the true
rates of excellent adherence.
Perhaps most concerning is that the overall mortality
among this cohort of transitioned teenagers was, at the
very least, 8.8 %. Though this is higher than that mortal-
ity rate recently reported among a cohort of transitioned
teens from the United Kingdom (0.9 per 100 person-
years) [16], it is consistent with global reports citing an
increase in the number HIV-related deaths among ado-
lescents, with HIV/AIDS now the second leading cause
among adolescents worldwide [21]. While difficulties
with the transition process may contribute to this, we
suspect that this likely reflects their poor health status
prior to transition while still under pediatric care. Given
their high rates of drug resistance and poor immuno-
logical status prior to transition [17], it is not surprising
that these same young adults may be failing therapy
under adult care. We suspect that those with difficulties
prior to transition continue have difficulties post-
transition, and that the challenges brought on by the
transition process may worsen the already fragile health
status of some. As much as efforts should be made to
improve the transition process, the health and social
welfare of these teenagers must be optimized prior to
transition.
With respect to the transition experience, an overall
theme that emerged was the difference in adult and
pediatric care practice styles, and the resulting difficulty
youth had in adapting. Pediatric care was more flexible
with respect to appointments, with frequent reminders
for missed visits, help with transportation to and from
clinic, and with obtaining medications. The loss of these
services was challenging for those who did not have the
tools to adapt. These results concur with previous
qualitative studies identifying barriers in the transition
process [22–25], including lack of communication be-
tween pediatric and adult care providers [26], lack of de-
velopmental readiness [27], and fear of attending clinics
with adults with horizontally-acquired HIV [23]. The
youth respondents in this study provided insight into
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ways of improving the transition process, with sugges-
tions that included increasing their preparedness for the
process with increased responsibility prior to transfer, a
period of shared care between adult and pediatric pro-
viders until successful transition had occurred, a special
young adult (18–25) clinic, and the possibility of main-
taining links to non-medical members of the pediatric
team. A delayed transition was also proposed by some,
with a preference towards 18–20 or until judged by both
patient and physician to be “ready”.
Conclusions
This study among a small group of perinatally-infected
youth after transfer to adult care demonstrates that
while a majority remained engaged in care after transi-
tion, difficulties with adherence and assuming responsi-
bility for their own care were identified as major issues
in their post-transition care. Our results must be inter-
preted with caution, as they may not be reflective of the
overall transitioned cohort of young adults. Those par-
ticipants we were unable to recruit likely represent those
at highest risk of adverse outcomes, and represent the
major limitation of this study. Moreover, our small sam-
ple size makes it difficult to generalize our findings. The
outcomes of those whom we were unable to contact or
who refused to participate may well be very different
than those reported, and yet are an important group
who may most benefit from any interventions. Finally,
the youth participants in this study were those who grew
up in an era of limited cART availability, and their health
outcomes may be very different from those perinatally-
infected youth currently engaged in care. Nonetheless,
given the limited data available on post-transition out-
comes, our study does provide some insight into the
post-transition world of HIV-infected youth, and sug-
gests that further efforts should be directed towards sys-
tematically following perinatally-infected youth and their
trajectory into adulthood, in order to best guide current
pediatric care and the transition process.
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